Daily FNArena News - Australia

Southern Cross Equities has initiated coverage on QRxPharma with a Speculative Buy rating, seeing the group’s MoxDuo drug as a potential company maker.

Brokers agree that Australian banks are already well positioned to comply with new international banking requirements stemming from the Basel III accord. But what happens now?

Stockbrokers continue to see value in Platinum Australia at current share price levels.

Market strategists at UBS and JP Morgan have made some changes as “valuation” becomes more of an issue. Analysts at RBS have discovered some good news.

Brokers argue the A-REIT sector is now looking a lot more like what it used to once upon a time, before the world went crazy on debt and crashed.

Stockbrokers are positive about a conditional agreement between Lend Lease and Japanese house builder Sekisui House.

The market was very disappointed yesterday when Santos sold 15% of GLNG to Total at well below the expected price, but brokers see bigger picture positives.

Another stronger than expected jobs market report in Australia is reigniting forecasts for an interest rate hike sooner rather than later.

Citi anticipates M&A action among Australia’s junior miners given Lihir has left a big hole, with Newcrest now just too big.

Morgan Stanley suggests Diversified Resources stocks are about to enjoy upgrades to market forecasts. Plus a rally for copper. Plus the latest views on media stocks in Australia.